Home › Funds › Farallon Capital Management › TWST
Farallon Capital Management position in TWST
TWIST BIOSCIENCE CORP · Health Care
Latest position (Q2 2026)2.14M sh
Reported value held$219.79M
Portfolio Weight1.02%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 192.00K | $9.46M | New |
| Q3 2024 | 340.65K | $15.39M | Add |
| Q4 2024 | 7.65K | $355.50K | Reduce |
| Q1 2025 | 7.65K | $300.34K | Hold |
| Q2 2025 | 7.65K | $281.44K | Hold |
| Q3 2025 | 7.65K | $215.27K | Hold |
| Q4 2025 | 7.65K | $242.66K | Hold |
| Q1 2026 | 1.43M | $67.84M | Add |
| Q2 2026 | 2.14M | $219.79M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TWST
- BlackRock Inc 5.83M sh · $600.19M · Q2 2026
- Fidelity Management & Research (FMR) 4.70M sh · $483.85M · Q2 2026
- ARK Invest 4.55M sh · $468.08M · Q2 2026
- Invesco Ltd 1.93M sh · $198.38M · Q2 2026
- Vanguard Group 5.78M sh · $183.22M · Q4 2025
- Geode Capital Management 1.62M sh · $166.63M · Q2 2026
- Goldman Sachs Group 1.41M sh · $144.90M · Q2 2026
- Morgan Stanley 1.19M sh · $122.41M · Q2 2026
- D. E. Shaw & Co 1.19M sh · $121.98M · Q2 2026
- Baillie Gifford & Co 1.09M sh · $111.81M · Q2 2026
- Citadel Advisors 964.04K sh · $99.18M · Q2 2026